SpaceX Lands on the Nasdaq-100: What Comes Next for Investors

SpaceX’s Nasdaq-100 inclusion will initially make it only ~1% of the index due to a small float, driving passive buying, though the stock already fell nearly 7% on debut in the index. Valuation remains the key risk: the shares around $148 imply a market cap of about $1.95T—over 100x 2025 revenue of $18.6B—while major AI-related ambitions (e.g., AI data centers in orbit) likely won’t be immediate. Net-net, index demand may not be enough to offset valuation concerns, so the article expects continued downside risk.

Analysis

The mechanical bid from passive inclusion is real but probably too small to offset the much larger supply overhang created by a sub-5% float and an initial valuation that already prices in years of perfect execution. In practice, this means the first-order “index demand” story is likely a one-day/one-week technical, while the dominant 1-3 month force is secondary shares and insider monetization as lockups roll. That dynamic usually compresses multiples in very large-cap, low-float IPOs because every incremental seller matters more than the index buyer.

The main loser is the marginal buyer who assumes index membership creates durable support. Existing Nasdaq-100 constituents face only trivial weight dilution, so this is not a meaningful sell signal for NDAQ, NVDA, or the broader megacap cohort; the bigger competitive effect is psychological, not economic, as speculative AI capital may temporarily rotate from profitable incumbents into a narrative-driven asset. If the market starts treating this as a “must-own AI infrastructure proxy,” it can briefly crowd out better risk-adjusted names, but that trade tends to unwind once the float expands.

The contrarian view is that the move is not overbought because of fundamentals alone, but because the market is likely underpricing how quickly a 100x-sales-style multiple can de-rate when there is no near-term earnings anchor. The key reversal catalysts are lockup expiries, any secondary offering, or a weak quarter that shows revenue growth is not matching the capitalization. Falsification would be sustained price action above the post-IPO range despite rising float and no acceleration in forward estimates.

Key Decisions for Investors

• Tactically fade strength in SPCX over the next 1-3 months: use a put spread or starter short on rallies back toward the post-IPO high zone, with the thesis that unlock-driven supply overwhelms passive demand; stop if the stock reclaims and holds above the upper end of the initial range on expanding volume.
• Avoid chasing the index-inclusion narrative in NDAQ or broad Nasdaq proxies: the float-adjusted weight is too small to create durable beta, so treat any move as a short-lived flow event rather than a new secular catalyst.
• Relative-value watch: long NVDA vs short SPCX if market starts paying for AI optionality without earnings visibility; this is a valuation-quality pair, not a fundamental hedge, and should only be initiated if SPCX remains richly valued while NVDA de-rates on sentiment.
• Set an alert for the first lockup/secondary filing over the next 180 days; if float expands faster than expected, expect a faster-than-typical multiple compression and increase short exposure.
• If SPCX sells off 15-20% without a change in revenue guidance, cover some of the short into panic rather than press—low-float names can overshoot both ways and squeeze violently on any positive headline.